GlaxoSmithKline, Johnson & Johnson Combination May Control HIV With Monthly Injections
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Monthly injections with HIV therapies from GlaxoSmithKline Plc (GSK) and Johnson & Johnson (JNJ) sustained levels of the drugs in blood that should control the virus, according to a study that suggests the shots may one day provide a safer, more convenient treatment option to daily pills.
Help employers find you! Check out all the jobs and post your resume.
Monthly injections with HIV therapies from GlaxoSmithKline Plc (GSK) and Johnson & Johnson (JNJ) sustained levels of the drugs in blood that should control the virus, according to a study that suggests the shots may one day provide a safer, more convenient treatment option to daily pills.
Help employers find you! Check out all the jobs and post your resume.